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ABSTRACT  
Cancer metastasis is the leading cause of cancer-related mortality worldwide. To date, several in 
vitro methodologies have been developed to understand the mechanisms of cancer metastasis and 
to screen various therapeutic agents against it. Nevertheless, mimicking an in vivo 
microenvironment in vitro is not possible; while in vivo experiments are complex, expensive and 
bound with several regulatory requirements. Herein, we report a novel in ovo model that relies 
on chicken embryo to investigate cancer cell invasion and metastasis to various organs of the 
body. In this model, we directly inject green fluorescent protein (GFP) expressing cancer cells to 
the heart of chicken embryo at 3 days of incubation, then monitor cell migration to various 
organs. To this end, we used a simple tissue processing technique to achieve rapid imaging and 
quantification of invasive cells. We were able to clearly observe the migration of GFP 
expressing cancer cells into various organs of chicken embryo. Organ specific variation in cell 
migration was also observed. Our new slide pressing based tissue processing technique 
improved the detectability of migrated cells. We herein demonstrate that the use of GFP 
expressing cancer cells allows easy detection and quantification of migrated cancer cells in the 
chicken embryo model, which minimizes the time and effort required in this types of studies 
compared to conventional histopathological analysis. In conclusion, our investigation provides a 
new cancer metastasis model that can be further improved to include more complex aspects, such 
as the use of multiple cell lines and anti-metastatic agents, thus opening new horizons in cancer 
biology and pharmaceutical research. 
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INTRODUCTION  
Cancer metastasis is deemed responsible of about 90% of cancer associated deaths [1]. This 
process is defined by cancer cell migration from a primary site to distal organs and subsequent 
formation of secondary tumours [2]. Therefore, development of therapeutic modalities that 
prevent tumour metastasis is needed to cope with this devastating disease [3]. During metastasis, 
cancer cells undergo various steps such as invasion, intravasation, survival in the circulation, 
extravasation, and proliferation within the tissues of a remote organ [4,5]. Thus, cancer cells 
have to overcome various barriers (e. g. blood brain barrier in the case of brain metastasis) [6], as 
well as diverse sets of conditions to be successful in reaching distal tissue and subsequent 
proliferation [7]. Nevertheless, understanding the biological mechanisms behind cancer 
metastasis in order to develop new therapeutic agents to target them remains a major challenge in 
cancer research [8]. Today, appropriate in vitro [9] and in vivo [10] biological models are needed 
for the identification and validation of anti-metastatic drugs [11,12].  
In general, in vitro cell migration models are simpler compared with the more complex in vivo 
ones [9]; however, in vitro models cannot mimic the complex physiological environment, that 
allows for the study of the various steps involved in metastasis which can only be achieved using 
in vivo models [13]. Nevertheless, in vitro cell migration assays are essential in cancer 
metastases research as they provide a controlled environment which enables to collection of 
quantitative and consistent data [14]. Some of these models include, transwell cell migration, 
wound healing or scratch, fence, spheroid migration, cell exclusion zone, micro-carrier bead, 
capillary tube, capillary chamber and colloidal particle assays, as well as time-lapse cell tracking 
[15]. This large number of migration assays that comprise both 2D in addition to the more 
complex 3D models, were developed to fulfill the need to study different types of cells and 
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answer a variety of aspects related to cancer development since no single in vitro model is 
sufficient on its own [16]. For instance, an in vitro 3D model for human head and neck squamous 
cell carcinoma (HNSCC) cannot mimic the systemic impact of invasion in vivo [17]. As a result 
of this insufficiency of the in vitro models despite their unquestionable importance in metastatic 
research, it is necessary to reexamine in vitro data using in vivo models. Nevertheless, in vivo 
procedures come with a new set of complications, ranging from administrative hurdles of 
obtaining ethical approval to the higher expenses of animal models [18]. In addition, in vivo 
experiments are time consuming, laborious, require high technical skills and high level of hands-
on experience.   However, they remain the most realistic model and provide the closest 
microenvironment to the human physiology which make them essential and mandatory before 
the start of any clinical trial [19]. 
On the other hand, it has been demonstrated for several decades that tumor tissues can be 
cultured within the chorioallantoic membrane (CAM) surrounding the chicken embryo [20,21] to 
study cancer metastasis [22]. In this regard, a relatively recent report used the CAM model to 
study HNSCC progression [17]. Although these earlier investigations were inspirational and laid 
the ground for the present study; such methods still rely on time consuming experimental 
procedures such as histopathological sectioning, polymerase chain reaction (PCR) based assays 
etc [23,24]. Moreover, rather than depositing cells on the CAM, direct injection of cancer cells 
into the embryo can be advantageous as this will ensure the presence of injected cells in the 
blood stream. 
In addition to the advances of in vitro and in vivo cell invasion models, robust imaging tools are 
required to detect migrated cells [25,26]. Thus, recent progresses in cell labelling, microscopy 
and imaging technologies facilitate cell tracking, however they remain complex and time 
6 
 
consuming [27,28]. Of these methods, fluorescent imaging enables easy visualization and 
tracking of fluorescently labelled individual cells that migrate to various organs of an animal 
[29]. Although fluorescent tags are largely available today, photobleaching and loss of 
fluorescence with time is a big challenge for their in vivo applicability. Conversely, advances in 
genetic engineering techniques such as transfection, allows the generation of cells that can 
express fluorescent molecules [30]. Green Fluorescent Protein (GFP) is a biomarker with wide 
range of applications for monitoring biological processes, tracking cells detecting transgenic 
expression,  and quantification of migrated cells in metastasis models in vitro and in vivo [31].  
Thus, given the large gap between in vitro and in vivo microenvironments that often effect the 
transfer of promising therapeutic results; the need for a new model that combines the flexibility 
and consistency of in vitro methods in a more complex physiology is an essential tool. Herein, 
we propose a relatively simple in ovo model using chicken embryos and GFP expressing cancer 
cells which can be considered as a bridge between the in vitro and in vivo models. 
MATERIALS AND METHODS  
The general steps of the chicken embryo in ovo model for studying cancer cell metastasis are 
shown in Figure 1. These include, (A) the generation of GFP expressing MDA-MB-231 (GFP-
MDA) cells by plasmid-based transfection, (B) injection of GFP-MDA-231 cells in chicken 
embryo, and (C) dissection of embryo after various time points, isolation of organs, microscopic 
slide preparation and microscopic detection of cancer cell invasion. Detailed description of each 
step is given in subsequent sections.  
Selection criteria and culture of cell line 
Selection criteria 
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In order to validate the proposed model, we used MDA-MB-231 cells which is one of the most 
commonly used breast cancer cell lines in cancer research that was isolated from the metastatic 
mammary adenocarcinoma of a 51-year-old Caucasian female [32]. MDA-MB-231 is a highly 
aggressive, invasive and poorly differentiated triple-negative breast cancer (TNBC) cell line with 
limited treatment options [33]. Studying the metastasis of triple-negative breast cancer is 
therefore crucial for finding novel treatment regimens.  
Cell culture conditions 
MDA-MB-231 cells are grown at 37°C in RPMI medium (Gibco) supplemented with 10% fetal 
bovine serum (FBS) (Gibco) and 1% penicillin streptomycin solution (Gibco). The cell line used 
in this study was at passage 37.  
Generation of GFP expressing MDA MB-231 cells 
Cells were cultured in 24 wells plate until they reached 70-90% confluence. Afterwards, cells 
were transfected using Lipofectamine (Invitrogen) and then serially diluted to obtain the clone of 
GFP positive MDA cells (GFP-MDA-231), the detailed protocol is listed below. After obtaining 
a stable cell line from the GFP positive cloned cells, they were diluted to the appropriate 
concentration for injecting in the embryo.  
Transfection procedure 
Three hundred thousand MDA-MB-231 cells were seeded in 6-well plates and cultured in RPMI 
medium containing 10% FBS until 70-90% confluence. Upon reaching the required confluence 
stage, media was replaced with 2 ml fresh media (antibiotic free). Then, 15 µg of the plasmid 
DNA was suspended in 1.5 ml of RPMI. Afterwards, 60 µl of Lipofectamine 2000 was mixed 
with another 1.5 ml RPMI. This was followed by an incubation period of 5 min at room 
temperature, then both solutions were combined and gently mixed. The mixture was incubated 
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for 20 minutes at room temperature, after which, 500 µl of the above mixture was added to each 
one of the six wells and incubated at 37°C in a CO2 incubator for 6 hours. Subsequent to the 
incubation period, the old media was replaced with 2 ml of fresh RPMI containing 10% FBS and 
incubated for 24 hours in a CO2 incubator.  Post 48 h of transfection, the GFP gene expression 
was visualized using a fluorescent microscope (Leica DMi8) and the wells with the best 
transfection rates were marked (i.e. the well containing the highest percentage of fluorescent 
cells).  
Stable GFP expressing MDA cell line (GFP-MDA-231) was established by single cell cloning 
method using a reported protocol [34]. The selection process was performed in a 96 well plate by 
serially diluting 2x104 cells/ml of transfected GFP-MDA-231 cell suspension to get a single cell 
in some of the wells. Serially diluted 96 well plate containing the cells was incubated in a CO2 
incubator for 48h. Then, the plate was observed under the fluorescent microscope (Leica DMi8) 
and wells with only fluorescent cells were marked. Upon reaching 90-100% confluence, GFP-
MDA cells were subcultured in a 12 wells plate and eventually moved to larger tissue culture 
flasks. 
Injection of GFP-MDA -231 cells into the embryo 
Incubation of the eggs 
Fertilized chicken eggs were purchased from the Arab Qatari for Poultry Production and placed 
in an egg incubator at 37° C with 70% humidity. Thirty eggs were used for each set of 
experiment. Three independent sets of experiments were performed to get reproducible results. 
The rack turning cycle was set at 1 turn per hour. Eggs were not sprayed with 70% ethanol or 
any kind of liquid disinfectant as this can significantly reduce the survival rate, but wiped with a 
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towel. The first day of incubation was considered as Egg Development Day (EDD) zero (EDD-
0). Injection procedure was performed at EDD-3.   
Injection procedure 
At EDD-3, the surface of the egg shell was disinfected with minimum amount of 70% ethanol 
and a very small circular window (4-6 mm) was made on the top blunt surface of the egg where 
the air sac was located and gradually widened (1.5 – 2 cm) using a surgical scissor. About 200 µl 
of sterile PBS was placed on the center of the egg membrane (inner shell membrane) using a 
micropipette under the microscope (Zeiss Stemi 508 stereo zoom). The inner shell membrane 
was punctured carefully using a tweezer without injuring the underlying CAM to allow PBS to 
spread between the two membranes and separate them. This facilitated the easy removal of the 
inner shell membrane without injuring the CAM.  
In order to inject the cells into the embryo, GFP-MDA-231 cells were suspended at a 
concentration of 5x106 cells/ml in serum free RPMI media. 10 µl of the cell suspension (5x104 
cells) was taken in a microinjection needle (Narishige, Glass Capillary) which was connected to 
a pneumatic microinjector (Narishige, IM-11-2) through a silicon tubing. The needle was used to 
pierce the CAM very carefully and inject the cells into the heart of the embryo. Then, the 
window in the eggshell was closed with a cellophane tape. For each experimental series, 5 
controls were kept without injecting anything into the embryo, another 5 controls were used in 
which 10 µl of RPMI medium was injected and the remaining 20 embryos were injected with 
GFP-MDA-231 cells to monitor the cell migration at different time frames ranging from 2 to 6 
days after injection.  
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Post injection of GFP-MDA-231 cells, the embryos were placed in the egg incubator by keeping 
the egg tray rack in static setting (at 37°C, 70% humidity). The major steps of the cancer cell 
injection process are shown in Figure 2. 
Isolation of organs and processing tissue samples for microscopy  
For the microscopic analysis and quantification of the migrated cancer cells to various organs of 
chicken embryo, organs were isolated after different time points and observed under fluorescent 
microscope as shown in Figure 3.  
Isolation of organs 
The embryos were dissected at EDD-5, EDD-7 and EDD-9 to isolate various organs from the 
embryo which were at 2nd, 4th and 6th day of post injection, respectively. Cellophane tapes were 
removed from the eggs using a blunt end tweezer and the embryos were transferred individually 
to petri dishes. In order to avoid cross-contamination, two separate sets of surgical tools were 
used, one set for dissecting controls and one set for dissecting GFP-MDA-231 injected embryos. 
Different wash containers filled with PBS were maintained to wash the tools before working on 
different embryos. Each isolated embryo was washed several times with PBS and transferred to 
another fresh petri dish containing PBS. Embryos were dissected using tweezers and scissors to 
extract heart, brain and liver, dissected organs were washed again individually in PBS. These 
organs were chosen for their ease of recognition and isolation. However, other organs or tissues 
can be isolated based on the specific needs of the research project.  
Observation of organs under a microscope 
Fluorescent microscopy was used to detect migrated cells to various organs of the chicken 
embryo. GFP-MDA-231 cells can be excited by 488 nm laser light and optically detected at 510 
nm using the GFP filter of inverted fluorescent microscope (Leica DMi8).  Repeated washing of 
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organs was used to remove any floating GFP-MDA-231 cells that might be present in body 
fluids. In order to visualize the migrated GFP-MDA-231 cells in the organs two different 
approaches were used, namely direct observation (without any tissue preparation) and a novel 
simple approach using microscopic slides.  
Direct observation of organs: Properly washed organs were transferred into the wells of 12 well 
plate and observed under the fluorescent microscope (Leica DMi8, 10X objective) with GFP 
filter to visualize the cells.  Entire parts of each organ were analyzed to find and image the 
migrated GFP-MDA-231 cells if any. Observed GFP positive cells were counted and tabulated.  
Preparation of microscopic slides: Imaging of thick samples using fluorescence microscopy was 
a challenging task due to the high level of background noise and difficulty of getting images of 
cells which were deep inside the tissues. Thus, we used a novel and simple approach to make 
thinner microscopic specimens.  For this, each isolated organ was minced into 2 – 4 pieces based 
on their size. Tissue pieces were placed between clean microscopic glass slides which were 
placed on a flat surface (a table) and pressed by hand firmly for about 10 seconds. The entire 
area of the glass slides (with the tissues) was observed under the fluorescent microscope (Leica 
DMi8, 10X objective) to detect and visualize the migrated GFP expressing cancer cells. Then, 
observed GFP positive cells were counted and tabulated. 
RESULTS 
Imaging of migrated cells in unprocessed tissue samples 
After the injection of transfected cancer cells into the heart of the embryo, they were dissected at 
days 2, 4 and 6 of injection. Images of the heart, brain and liver were taken under fluorescent 
microscope to confirm the presence of migrated cells. Pictures of GFP-MDA-231 cells in heart, 
brain and liver of intact organs of chicken embryo are shown in Figure 4 and Table 1. In many 
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cases, GFP-MDA-231 cells were not clearly identifiable in intact organs under the microscope 
because of the higher thickness of the samples for microscopic observation, this was especially 
apparent for the liver and brain. In general, heart tissues possessed the highest number of GFP 
expressing cells, which is consistent with it being the primary injection site. However, cells 
remained in colonies or aggregates which made cell counting particularly difficult. On the other 
hand, the brain contained a smaller number of migrated GFP cells compared to the heart, while 
liver tissues showed no migrated GFP expressing cells. Since migrated cells were mostly in 
aggregates, data obtained from direct imaging of organs cannot be properly quantified which 
necessitates the use of the tissue sampling process described above, followed by microscopic 
analysis.  
Imaging of migrated cells in glass slides containing manually pressed tissue samples 
Due to the difficulties in obtaining consistent results from direct imaging of isolated organs, we 
used the slide pressing technique to get thin specimens of tissues, which was very simple, fast, 
and efficient. After pressing the organs between microscopic slides, migrated GFP-MDA-231 
cells were easily detectable. Moreover, quantification of migrated cells was more reliable and 
reproduceable compared to directly imaged organs. Figure 5 and Table 2 show observed GFP-
MDA-231 cells in heart, brain and liver of the chicken embryos. Unlike unprocessed organs, we 
did not observe aggregated GFP-MDA-231 cells which facilitated the detection and 
quantification process. Thus, the number of migrated cells obtained in pressed organs were 
higher compared to those observed in the organs without slide pressing.  
As observed, the heart showed the highest number of GFP-MDA-231 cells with the least number 
of GFP expressing cells on Day-2 after injection. However, on Days 4 and 6, there is an increase 
in the number of GFP-expressing cells which can be ascribed to cell proliferation. Brain and liver 
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tissues also showed a relatively similar trend; however, migrated cells were less in comparison 
with the heart. Most importantly, using this method we were able to detect migrated GFP-MDA-
231 cells in the liver, which were not detectable in intact organs. 
DISCUSSION  
Use of chicken embryo-based metastasis models provides ample opportunities, and yet harbor 
some challenges for qualitative and quantitative imaging and image analysis. On the other hand, 
histopathological analysis enables tracking of migrated cells into various organs [35]. However, 
such approaches are both time consuming and laborious. Thus, we developed a simple method 
for studying cancer metastasis using chicken embryos and image analysis to detect migrated 
cancer cells to various organs. This simple and manual technique allows for quick recovery of 
quantitative data using tools that are readily available in any biological lab.  
While other researchers described the use of chicken embryo models to study cancer metastasis 
[36], most of them rely on the CAM assay which is considerably different from our model where 
we directly inject cancer cells into the heart of the embryo. In one such study, the CAM model 
was used to examine ovarian cancer cell invasion and metastasis to the posterior CAM and lungs 
of chick embryos using various cells such as IGROV-1 [37], OVCAR-3, SKOV-3 and OV-90 
[38]. Admittedly, while, this CAM model may mimic cell migration across peritoneum, 
nevertheless, it may not be an appropriate model for cell migration to other organs such as brain, 
liver or lungs. Slide preparation technique used in this study was a very simple approach and 
allow the quick quantification of migrated fluorescently labelled cancer cells to various organs of 
the embryo. Such a quick and accurate quantification of metastatic cells was not possible in 
earlier chicken embryo based models [39].  
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Therefore, we believe that there are several advantages for our model over existing in vitro and 
in vivo ones of cancer metastasis, such as cost effectiveness, speed of performing and obtaining 
results as well as simplicity of experimental procedures. It also provides a more realistic and 
complex bio-microenvironment compared to in vitro models [40]. Most importantly, this model 
is highly flexible and can be adapted with minor modifications to suit a vast variety of 
applications. For instance, it can aid in understanding the mechanisms of cancer metastasis as 
well as the effect of certain inhibitors, drugs or radiation on cancer metastasis using various cell 
types. Earlier studies from our group using the chicken embryo CAM assay and in vitro cell 
culture studies have shown that cell-phone radio frequency can promote angiogenesis and cancer 
cell invasion [41]; additionally, the effect of cell-phone radiofrequency on cancer cell metastasis 
can also be verified using this model. Our ex ovo model also overcome some of the limitations of 
widely used zebra fish models [42]. In this regard, it is worth noting that most mammalian 
tumors proliferate at 37°C which is also the optimum temperature to incubate the chicken 
embryos; unlike the zebra fish model which optimally grows at 31°C [43].  
Moreover, this model avoids several ethical and regulatory complications since it uses chicken 
embryos of less than 10 days of incubation (EDD-10). As such, chicken embryos that are ≤14 
days of incubation are not considered as living organisms that can experience pain in several 
countries [44][45]; hence, ethical approvals are not required to perform experiments with 
chicken embryos ≤EDD-10.  However, this may vary with different countries or depending on 
the regulations of individual institutions. On the other hand, direct injection of cancer cells into 
the developing heart allows embryos to be analysed at much earlier stages than other chicken 
embryo-based approaches such as CAM based models.  
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Nevertheless, in spite of the numerous advantages of this model, several precautionary measures 
need to be taken, most specifically pertaining to the injection of cancer cells into the embryo. 
This critical process needs to be consistent and performed delicately in order to avoid 
premature death of embryo and to obtain reliable results. In this study, eggs were observed 
every 24 h for signs of embryo discoloration, if any. Those with colour variations were 
opened by removing the cellophane tape and dead eggs were counted, tabulated and 
discarded. Handling associated death was then compared between controls and cancer cell 
injected chicken embryos within 24-48 h of injection, we noticed that a relatively small 
number of embryos died after 24-48 h of injection (data not shown).  
CONCLUSION 
Due to the growing importance of understanding cancer metastasis, various models are in 
developmental or testing stage to screen new genes and compounds that can prevent this fatal 
disease. Most importantly, focus on components of the tumour microenvironment, such as the 
extracellular matrix, miRNA profiles, pH, fluid flow, and interstitial pressure with regards to 
their role in cancer metastasis has opened new avenues in metastatic cancer research and therapy. 
Therefore, inclusion of these components in metastasis models is necessary to mimic the actual 
tumour microenvironment for better screening of drugs as well as oncogenic initiatives. Our 
study suggests that chicken embryo based in ovo metastasis models could be a promising 
strategy for mimicking such an environment. In this study, we were able to demonstrate that 
fluorescently labelled MDA-MB-231 cancer cells migrated to various organs such as brain and 
liver where they can potentially proliferate for a period of up to 6 days. Use of GFP expressing 
cancer cells allows easy detection and quantification of such migrated cancer cells. Moreover, 
application of our slide pressing approach improves the quantification and detection of migrated 
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cancer cells into various tissues and organs. This minimizes the time and effort required 
compared to conventional histopathological analysis. Thus, the combination of these approaches 
with further improvements such as the use of multiple cell lines and anti-metastatic agents, can 
open new horizons in cancer biology and pharmaceutical research. 
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FIGURES AND TABLES 
 
Table 1 Migrated GFP-MDA-231 cells quantified using fluorescent images of organs isolated from chicken 
embryos at days 2, 4 and 6 of post injection 
 Day-2 Day-4 Day-6 
Heart 2 ± 0.8 2 ± 0.9 1 ± 1 
Brain 1.5 ± 1.2 1.6 ± 2 2 ± 1 
Liver 0 0 0 
 
Table 2 Migrated GFP-MDA-231 cells quantified from the fluorescent images of pressed organs which 
were isolated from the chicken embryos at days 2, 4 and 6 of post injection 
 Day-2 Day-4 Day-6 
Heart 5.7 ± 1.7 13 ± 2.5 21.5 ± 2 
Brain 1 ± 0.8 1.5 ± 1.2 2 ± 0.8 
Liver 0.5 ± 0.5 0.75 ± 0.5 2 ± 1 
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Figure 1 Schematic representation of the process flow of the developed metastasis models 
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Figure 2 Steps of the injection process of GFP-MDA-231 cells in the chicken embryo. A and B. incubation 
of the eggs; C. surface sterilization of eggs using tissue paper wetted with 70% ethanol; D. making a hole 
in the eggshell; E. removal of the egg membrane to expose the CAM; F. locating the injection site under 
the microscope; G. Injection of GFP-MDA-231 cells; H. sealing of the shell window using cellophane tape; 
I. Incubation of the eggs. 
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Figure 3 Isolation of organs from chicken embryo after different time points of injection of GFP-MDA-
231 cells. A) Egg containing embryo injected with cancer cells; B) Embryo with extraembryonic fluids 
transferred to a petri dish; C) Isolated embryo; D) Dissection of embryo to isolate various organs; E) 
Isolated embryonic organs; F) Transferring parts of isolated organs into a clean microscopic glass slide; G) 
Arranging parts of isolated organ between two slides; H) Pressing of organs between glass slides; I) 
Observing the slides under fluorescent microscope 
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Figure 4 GFP-MDA-231 cells detected in various organs of the chicken embryo at days 2, 4 and 6 of post 
injection (Scale bar: 200 µm) 
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Figure 5 GFP-MDA-231 cells detected in pressed samples of various organs of chicken embryos at days 
2, 4 and 6 of post injection (Scale bar: 200 µm) 
 
